Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Clinicopathological study of renal biopsies after liver transplantation.

Chan GS, Lam MF, Kwan L, Fung SH, Chan SC, Chan KW.

Hong Kong Med J. 2013 Feb;19(1):27-32.

2.

Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.

Chan GS, Lam MF, Au WY, Chim S, Tse KC, Lo SH, Fung SH, Lai KN, Chan KW.

Nephrology (Carlton). 2008 Jun;13(4):322-30. doi: 10.1111/j.1440-1797.2007.00915.x. Epub 2008 Jan 23.

PMID:
18221254
3.

Renal histopathological lesions after orthotopic liver transplantation (OLT).

Pillebout E, Nochy D, Hill G, Conti F, Antoine C, Calmus Y, Glotz D.

Am J Transplant. 2005 May;5(5):1120-9.

4.
5.

Clinicopathologic study of kidney biopsies in patients before or after liver transplant.

Terzi A, Özdemir BH, Taşlıca FZ, Özdemir FN, Kırnap M, Haberal M.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:129-35.

6.

Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.

Kubal C, Cockwell P, Gunson B, Jesky M, Hanvesakul R, Dronavalli V, Bonser RS, Neil D.

Transplantation. 2012 Feb 27;93(4):406-11. doi: 10.1097/TP.0b013e318240e984.

PMID:
22217532
7.

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.

Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.

Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. Epub 2005 Jun 28.

PMID:
15985508
8.

Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.

Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.

Transplant Proc. 2009 Sep;41(7):2789-93. doi: 10.1016/j.transproceed.2009.07.094.

PMID:
19765436
9.

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.

Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.

Kidney Int. 1999 Feb;55(2):674-85.

10.

Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.

Prasad N, Gupta P, Jain M, Bhadauria D, Gupta A, Sharma RK, Kaul A.

Exp Clin Transplant. 2013 Jun;11(3):215-21.

11.

Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.

Yagisawa T, Omoto K, Shimizu T, Ishida H, Tanabe K.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:51-7. doi: 10.1111/nep.12461.

PMID:
26031587
12.

A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.

Singh L, Singh G, Sharma A, Sinha A, Bagga A, Dinda AK.

Hum Pathol. 2015 Jan;46(1):34-9. doi: 10.1016/j.humpath.2014.09.003. Epub 2014 Oct 2.

PMID:
25449629
13.

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.

Lee JH, Cho YH, Ryu SJ, Kim SS, Lee YH, Jang IA, Choi BS, Choi JY, Kim DG, Choi YJ, Yang CW, Chung BH.

Kidney Res Clin Pract. 2013 Dec;32(4):153-7. doi: 10.1016/j.krcp.2013.08.002. Epub 2013 Oct 24.

14.

Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation.

Calmus Y, Conti F, Cluzel P, Hill G, Antoine C, Scatton O, Soubrane O, Glotz D, Pillebout E, Nochy D.

J Hepatol. 2012 Sep;57(3):572-6. doi: 10.1016/j.jhep.2012.04.028. Epub 2012 May 18.

PMID:
22612996
15.

Long-term outcomes of calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.

Mackay AJ, Angus PW, Gow PJ.

Transplant Proc. 2011 Dec;43(10):3802-6. doi: 10.1016/j.transproceed.2011.10.044.

PMID:
22172850
16.

The variable pathology of kidney disease after liver transplantation.

Kim JY, Akalin E, Dikman S, Gagliardi R, Schiano T, Bromberg J, Murphy B, de Boccardo G.

Transplantation. 2010 Jan 27;89(2):215-21. doi: 10.1097/TP.0b013e3181c353e5.

PMID:
20098285
17.

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.

Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.

Liver Transpl. 2009 Dec;15(12):1792-7. doi: 10.1002/lt.21920.

18.

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.

Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ.

Liver Transpl. 2003 Oct;9(10):1079-85.

19.

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

Rerolle JP, Thervet E, Anglicheau D, Desgrandchamps F, Nochy D, Janin A, Fornairon S, Passa P, Bedrossian J, Legendre C.

Nephrol Dial Transplant. 2002 May;17(5):905-9.

PMID:
11981082
20.

A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation.

Urbani L, Mazzoni A, Bindi L, Biancofiore G, Bisà M, Meacci L, Esposito M, Mozzo R, Colombatto P, Bianco I, Grazzini T, Coletti L, De Simone P, Catalano G, Montin U, Tincani G, Balzano E, Petruccelli S, Carrai P, Tascini C, Menichetti F, Scatena F, Filipponi F.

Clin Transplant. 2009 Nov-Dec;23(6):853-60. doi: 10.1111/j.1399-0012.2009.00957.x. Epub 2009 Jan 30.

PMID:
19220362

Supplemental Content

Support Center